← Back to Influence Map
Entity DossierOrganization
ADVOCATES FOR COMMUNITY HEALTH
DC · US
Membership org focused on policy and advocacy initiatives for the health care system
pharmaceuticals
Tracked direct giving
$0
Tracked donations to candidate
$0
LDA reported lobbying spend
$1,130,000
Connections
5
Lobbying Activity Detail
Disclosed lobbying expenditures from LDA filings where this entity is the client. Dollar amounts represent what was reported to the Senate Office of Public Records.
Top Lobbying Issues
HCRHealth Issues
$1.9MMMMMedicare/Medicaid
$240KBUDBudget/Appropriations
$220KLobbying Firms Retained
ADVOCATES FOR COMMUNITY HEALTH$1.1M
CROSSROADS STRATEGIES, LLC$330K
VENN STRATEGIES$240K
TARPLIN, DOWNS & YOUNG, LLC$220K
Bills Referenced in Lobbying Filings
insulin
Lobbying data from Senate LDA filings and the LobbyView dataset (MIT/NSF, CC-BY-4.0). Dollar figures represent disclosed expenditures only and may not capture all influence activity. Issue codes follow the LDA general issue classification.
Connection Graph
0 nodes · 0 edgesHover for labels · Double-click to expand
Loading graph...
Person
Organization
PAC
Gov Body
Legislature
Think Tank
Industry
Outcome
Click a node to see details
Double-click to expand its connections
Relationships
| Type | Connected To | Details | Source |
|---|---|---|---|
| Lobbied for | Insulin Price Caps - State-Level Legislation | LDA filing: lobbied on Insulin Price Caps, period 2nd Quarter (Apr 1 - June 30), reported amount $115,000 | Source |
| commented_on | Centers for Medicare & Medicaid Services | Public comment on CMS-2023-0070: Medicaid Program: Ensuring Access to Medicaid Services (CMS-2442-P) | Source |
| Employed by | CROSSROADS STRATEGIES, LLC | Hired CROSSROADS STRATEGIES, LLC to lobby (1st Quarter (Jan 1 - Mar 31) 2024) | Source |
| Employed by | TARPLIN, DOWNS & YOUNG, LLC | Hired TARPLIN, DOWNS & YOUNG, LLC to lobby (1st Quarter (Jan 1 - Mar 31) 2023) | Source |
| Employed by | VENN STRATEGIES | Hired VENN STRATEGIES to lobby (2nd Quarter (Apr 1 - June 30) 2025) | Source |